摘要:
A process for preparing a coated composition comprising a pharmaceutically active substance stable to heat, which comprises centrifugally granualting a mixture comprising said active substance and a first thermomelting material as a binder under heating without using any solvent and coating the resultant granules with a second thermomelting material as a coating material under heating, the melting point of the second thermomelting material being lower than that of the first thermomelting material.
摘要:
DNA encoding an endothelin receptor shown in SEQ ID NO: 1 or 2 in the Sequence Listing is isolated from cDNA which is prepared from poly(A)⁺RNA derived from a human placenta. In addition, an expression vector containing the DNA and a transformant containing the expression vector are obtained. An endothelin receptor is obtained by culturing this transformant. A receptor shown in SEQ ID NO: 1 is an ET A -receptor which has a high affinity for endothelins 1 and 2, especially for the endothelin 1. A receptor shown in SEQ ID NO: 2 is an ET B -receptor which has an affinity for endothelins 1, 2 and 3 with no selectivity.
摘要翻译:从序列表中SEQ ID NO:1或2所示的内皮素受体编码的DNA从由人胎盘的聚(A)+ RNA制备的cDNA中分离。 此外,获得含有DNA的表达载体和含有表达载体的转化体。 通过培养该转化体获得内皮素受体。 SEQ ID NO:1所示的受体是对内皮素1和2具有高亲和力的ETA-受体,特别是内皮素1。SEQ ID NO:2所示的受体是ETB受体,其对 内皮素1,2和3,没有选择性。
摘要:
A novel thioalkylthio cephalosporin antibiotic compound of formula I : wherein Acyl is C 1 - C 12 acyl ; Het is optionally substituted monocyclic heteroaromatic group containing one or more hetero atoms ; R 1 is a single bond or C 1 - C 4 alkylene ; R 2 is a straight or branched C 1 - C 4 alkylene ; X is a sulfur atom or sulfoxide group ; and Y is a hydrogen atom or methoxy group, or a pharmaceutically acceptable salt or an amino-, carboxy- and/or hydroxy-protected derivative thereof, a formulation containing the same and a method for treating bacterial infections.
摘要:
The radioactive iodine compound of this invention or an intermediate for preparing the compound is represented by the following formula (I):
wherein R is H or ¹²⁵I. The radioactive compound can readily introduce a radioactive isotope element such as ¹²⁵I into an antibody molecule without damaging the activity of the antibody molecule. Therefore, the compound can preferably be used to label an antibody of immunoradiometric assay, and allow a higher degree of measurement sensitivity.